Samsung Bioepis Co., Ltd. today announced the launch of OBODENCE™ (60 mg pre-filled syringe) and XBRYK™ (120 mg vial), denosumab biosimilars referencing Prolia and Xgeva. The products will be ...

Samsung Bioepis Co., Ltd. today announced the launch of OBODENCEtm (60 mg pre-filled syringe) and XBRYKtm (120 mg vial), denosumab biosimilars referencing Prolia and Xgeva. The products will be ...

Justice Department could present a new indictment against James Comey to a grand jury this week Amid anti-drug push, Trump ...

The NASA/ESA/CSA James Webb Space Telescope has captured a stunning view of the Pismis 24 star cluster located in the core of the Lobster Nebula. Travel 5,500 light years to the amazing imagery in ...

Google, like Spotify has released its version of the latter “Wrapped”, where it showcased what Indians have been searching ...

U.S. markets were leaning toward modest gains before the opening bell as technology and cryptocurrency companies recouped ...

Consolidation will be the catalyst to prune linear TV as pay TV subscriptions are poised to account for less than half of U.S. households by year's end ...

Samsung launched its first triple-folding phone on Tuesday, a special-edition product with an eyewatering price tag placing ...

OBODENCE (60 mg pre-filled syringe) and XBRYK (120 mg vial) become available across Europe as of December 2025 and January 2026, respectively Marks Samsung Bioepis' 10th and 11th biosimilars ...

This update to the Jitterbug adds Bluetooth and text messaging, while stepping up to larger displays. Other aspects are similar, including unique features for older users, such as a dial tone, padded ...

PureWow editors select every item that appears on this page, and some items may be gifted to us. Additionally, PureWow may earn compensation through affiliate links within the story. All prices are ...

Nvidia Corporation stock is a value buy in 2026 as AI demand boosts outlook and China risks fade. Click for this updated look ...